9 Meters Biopharma Inc (NMTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,869 | -43,766 | -31,837 | -22,482 | -11,352 |
| Depreciation Amortization | 580 | 1,840 | 506 | 4 | 2 |
| Accounts payable and accrued liabilities | -822 | 2,619 | -997 | -108 | -523 |
| Other Working Capital | 2,309 | 661 | 209 | 1,979 | 912 |
| Other Operating Activity | 2,052 | 1,403 | 4,614 | 3,072 | 1,213 |
| Operating Cash Flow | $-9,750 | $-37,243 | $-27,505 | $-17,535 | $-9,748 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -3 | -3 | -3 | -3 |
| Investing Cash Flow | $N/A | $-3 | $-3 | $-3 | $-3 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 21,000 | 21,000 | N/A | N/A |
| Common Stock Issued | 5,000 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -17,286 | -1,088 | -1,088 | 0 | 0 |
| Financing Cash Flow | $-12,286 | $19,912 | $19,912 | $N/A | $N/A |
| Beginning Cash Position | 29,659 | 46,993 | 46,993 | 46,993 | 46,993 |
| End Cash Position | 7,624 | 29,659 | 39,398 | 29,456 | 37,242 |
| Net Cash Flow | $-22,035 | $-17,334 | $-7,596 | $-17,538 | $-9,751 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,750 | -37,243 | -27,505 | -17,535 | -9,748 |
| Capital Expenditure | N/A | -3 | -3 | -3 | -3 |
| Free Cash Flow | -9,750 | -37,246 | -27,507 | -17,538 | -9,751 |